BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...
Topline data from registrational trial in stiff person syndrome (SPS) now expected in early 2026; narrowed from previous ...
Reached agreement with FDA on pivotal study design for TSC-101 following productive end of Phase 1 meeting Data from ALLOHA™ Phase 1 heme trial to be presented at the 67th American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback